Compound Specifications Synthetic Pentadecapeptide Laboratory Research Use Only Product Details Sizes: 5mg, 10mg Compound: BPC-157 Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val CAS: 137525-51-0 Molecular Weight: 1419.53 Da Form: Lyophilized powder Documentation: Batch-specific analytical records where available Testing: View COA documentation Testing: View COA (Verified by Janoshik) BPC-157 documentation path This page is built as a documentation-first reference page for researchers comparing compound identity, vial size, analytical records, and literature context
Re de leeuw SP, et al
The impact on fetus during pregnancy or children during breastfeeding has not been studied to sufficient extent, hence there is a need for caution
Intron-spanning primers for PPG were designed with IDT (Integrated DNA Technologies)
Predrag Sikiric is listed in [9] and [16] under the referenced citations
In addition to conventional GLP-1 agonists like Ozempic and Wegovy, which only target the GLP-1 receptor, she is also researching medications like Mounjaro, which also targets the GIP receptor, and even the just-released retatrutide, which targets the glucagon receptor in addition to GLP-1 and GIP receptors